Lista de obras - Giuseppe Alberto Palumbo

A physiological role for the neuropeptide luteinizing hormone-releasing hormone (LHRH) during the maturation of thymus gland function

artículo científico publicado en 1990

Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes.

artículo científico publicado en 2015

Alternation of epirubicin and mitoxantrone in CHOP-like regimens retains efficacy and reduces overall toxicity in elderly patients with high and intermediate grade non-Hodgkin lymphomas.

artículo científico publicado en 2002

Angiogenesis in chronic myeloproliferative diseases.

artículo científico publicado en 2001

Antitumor activity of bortezomib alone and in combination with TRAIL in human acute myeloid leukemia.

artículo científico publicado en 2008

Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study ⬇️

artículo científico publicado el 10 de septiembre de 2012

BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint.

artículo científico publicado en 2011

Baseline factors associated with response to ruxolitinib: an independent study on 408 patients with myelofibrosis

artículo científico publicado en 2017

Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II study.

artículo científico publicado en 2012

Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study.

artículo científico publicado en 2015

Broad copy neutral-loss of heterozygosity regions and rare recurring copy number abnormalities in normal karyotype-acute myeloid leukemia genomes.

artículo científico publicado en 2010

CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia.

artículo científico publicado en 2009

Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53

artículo científico publicado en 2019

Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategy.

artículo científico publicado en 2014

Clonal selection of 11q CN-LOH and CBL gene mutation in a serially studied patient during MDS progression to AML

artículo científico publicado en 2010

Comparison of JAK2(V617F) -positive essential thrombocythaemia and early primary myelofibrosis: The impact of mutation burden and histology

artículo científico publicado en 2017

Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma

scientific article published on 28 October 2019

Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome

scientific article published on 22 August 2019

Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a lar

artículo científico publicado en 2018

Drug-Related Cutaneous Adverse Events in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Literature Review

artículo científico publicado en 2020

Early lenalidomide treatment for low and intermediate-1 International Prognostic Scoring System risk myelodysplastic syndromes with del(5q) before transfusion dependence.

artículo científico publicado en 2015

Effects of micronised microencapsulated ferric pyrophosphate supplementation in patients with advanced cancer and iron deficiency: a single-centre cohort pilot study

scientific article published on 18 February 2019

Effects of second-generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donors

artículo científico publicado en 2011

Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent study

artículo científico publicado en 2017

Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis.

artículo científico publicado en 2001

Endoscopic features of gastro-intestinal lymphomas: from diagnosis to follow-up

artículo científico publicado en 2014

Endoscopic ultrasonography in gastric lymphomas: appraisal on reliability in long-term follow-up

artículo científico publicado en 2011

Erythrocytapheresis is a valid and safe therapeutic option in dysmetabolic iron overload syndrome

artículo científico publicado en 2015

Evaluation of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patients.

artículo científico publicado en 2004

Evaluation of Taxol cytotoxicity on B-CLL cells in vitro

artículo científico publicado en 1997

FcgammaRIIIA and FcgammaRIIA polymorphisms do not predict clinical outcome of follicular non-Hodgkin's lymphoma patients treated with sequential CHOP and rituximab

artículo científico publicado en 2007

Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients.

artículo científico publicado en 2004

Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC)

artículo científico publicado en 2016

Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells.

artículo científico publicado en 2011

Immune off-target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma

artículo científico publicado en 2019

Immunoproteasome Genes Are Modulated in CD34+ JAK2V617F Mutated Cells from Primary Myelofibrosis Patients

scientific article published on 22 April 2020

Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib

scientific article published on 07 June 2019

Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib

scientific article published on 04 December 2018

In vitro apoptotic response of freshly isolated chronic myeloid leukemia cells to all-trans retinoic acid and cytosine arabinoside

artículo científico publicado en 2000

In vitro sensitivity of B-CLL cells to fludarabine and interferons

artículo científico publicado en 1995

Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide

artículo científico publicado en 2017

Infection control in patients with myelodysplastic syndromes who are candidates for active treatment: Expert panel consensus-based recommendations

scientific article published on 28 October 2018

Inhibition of TLR4 Signaling Affects Mitochondrial Fitness and Overcomes Bortezomib Resistance in Myeloma Plasma Cells

artículo científico publicado en 2020

Intravenous injection of bortezomib, melphalan and dexamethasone in refractory and relapsed multiple myeloma

artículo científico publicado en 2012

Iron toxicity - Its effect on the bone marrow

artículo científico publicado en 2018

Is endoscopic ultrasound clinically useful for follow-up of gastric lymphoma?

artículo científico publicado en 2006

Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine-Results from the Italian 'Back to Life' project

artículo científico publicado en 2018

Luteinizing hormone-releasing hormone (LHRH) agonist restoration of age-associated decline of thymus weight, thymic LHRH receptors, and thymocyte proliferative capacity.

artículo científico publicado en 1989

M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro.

artículo científico publicado en 2009

Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of Ruxolitinib

artículo científico publicado en 2019

Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients

artículo científico publicado en 2016

Minimal Residual Disease Assessment Within the Bone Marrow of Multiple Myeloma: A Review of Caveats, Clinical Significance and Future Perspectives

scientific article published on 20 August 2019

Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells

artículo científico publicado en 2020

Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic Syndromes

artículo científico publicado en 2021

Monocytic Myeloid Derived Suppressor Cells in Hematological Malignancies ⬇️

artículo científico publicado en 2019

Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib

artículo científico publicado en 2017

Multicentric Castleman Disease and Concurrent Hematological Disorders: The Occurrence of Plasmacytoma and the Hypotheses Arising from Literature Review

artículo científico publicado en 2023

Multidrug resistance mechanisms in chronic lymphocytic leukaemia

artículo científico publicado en 2002

Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population.

artículo científico publicado en 1999

Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients.

artículo científico publicado en 2014

Nasal neutrophilia and eosinophilia induced by challenge with platelet activating factor

artículo científico publicado en 1994

Neuroendocrine modulation of lymphocyte's activity during the physiological menstrual cycle

scientific article published on 01 September 1990

Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation.

artículo científico publicado en 2009

PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy.

artículo científico publicado en 2018

Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes

artículo científico publicado en 2017

Peptidergic modulation of immune system development: Role of luteinizing hormone-releasing hormone

article

Peripheral blood stem cell contamination evaluated by a highly sensitive molecular method fails to predict outcome of autotransplanted multiple myeloma patients.

artículo científico publicado en 2003

Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy Via STAT3

scientific article published on 19 July 2019

Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy.

artículo científico publicado en 2018

Prognostic value of CD34+ peak in peripheral blood during mobilization in intermediate-risk AML patients treated in first CR by autologous or allogeneic transplantation

artículo científico publicado en 2011

Proteomic Analysis Reveals Autophagy as Pro-Survival Pathway Elicited by Long-Term Exposure with 5-Azacitidine in High-Risk Myelodysplasia.

artículo científico publicado en 2017

Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by Rituximab

artículo científico publicado en 2003

Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis

artículo científico publicado en 2021

Ruxolitinib in elderly patients with myelofibrosis: impact of age and genotype. A multicentre study on 291 elderly patients

artículo científico publicado en 2018

SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation

artículo científico publicado en 2013

Salvage therapy with pegylated liposomal doxorubicin, bortezomib, cyclophosphamide, and dexamethasone in relapsed/refractory myeloma patients.

artículo científico publicado en 2014

Significant co-expression of WT1 and MDR1 genes in acute myeloid leukemia patients at diagnosis.

artículo científico publicado en 2004

Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders.

artículo científico

TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma

artículo científico publicado en 2019

The Role of Inflammation and Inflammasome in Myeloproliferative Disease

scientific article published on 22 July 2020

The Role of New Technologies in Myeloproliferative Neoplasms

artículo científico publicado en 2019

The apoptotic machinery as a biological complex system: analysis of its omics and evolution, identification of candidate genes for fourteen major types of cancer, and experimental validation in CML and neuroblastoma

artículo científico publicado en 2009

The efficacy of rituximab plus Hyper-CVAD regimen in mantle cell lymphoma is independent of FCgammaRIIIa and FCgammaRIIa polymorphisms

artículo científico publicado en 2007

The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study.

artículo científico publicado en 2015

The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib

scientific article published on 09 July 2018

Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practice

scientific article published on 12 December 2019

Vascular endothelial growth factor polymorphisms in mantle cell lymphoma

scientific article published on 19 December 2009

α-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron Overload ⬇️

artículo científico

Lista de obras de Giuseppe Alberto Palumbo

A physiological role for the neuropeptide luteinizing hormone-releasing hormone (LHRH) during the maturation of thymus gland function

Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes.

Alternation of epirubicin and mitoxantrone in CHOP-like regimens retains efficacy and reduces overall toxicity in elderly patients with high and intermediate grade non-Hodgkin lymphomas.

Angiogenesis in chronic myeloproliferative diseases.

Antitumor activity of bortezomib alone and in combination with TRAIL in human acute myeloid leukemia.

Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study ⬇️

BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint.

Baseline factors associated with response to ruxolitinib: an independent study on 408 patients with myelofibrosis

Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II study.

Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study.

Broad copy neutral-loss of heterozygosity regions and rare recurring copy number abnormalities in normal karyotype-acute myeloid leukemia genomes.

CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia.

Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53

Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategy.

Clonal selection of 11q CN-LOH and CBL gene mutation in a serially studied patient during MDS progression to AML

Comparison of JAK2(V617F) -positive essential thrombocythaemia and early primary myelofibrosis: The impact of mutation burden and histology

Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma

Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome

Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a lar

Drug-Related Cutaneous Adverse Events in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Literature Review

Early lenalidomide treatment for low and intermediate-1 International Prognostic Scoring System risk myelodysplastic syndromes with del(5q) before transfusion dependence.

Effects of micronised microencapsulated ferric pyrophosphate supplementation in patients with advanced cancer and iron deficiency: a single-centre cohort pilot study

Effects of second-generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donors

Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent study

Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis.

Endoscopic features of gastro-intestinal lymphomas: from diagnosis to follow-up

Endoscopic ultrasonography in gastric lymphomas: appraisal on reliability in long-term follow-up

Erythrocytapheresis is a valid and safe therapeutic option in dysmetabolic iron overload syndrome

Evaluation of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patients.

Evaluation of Taxol cytotoxicity on B-CLL cells in vitro

FcgammaRIIIA and FcgammaRIIA polymorphisms do not predict clinical outcome of follicular non-Hodgkin's lymphoma patients treated with sequential CHOP and rituximab

Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients.

Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC)

Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells.

Immune off-target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma

Immunoproteasome Genes Are Modulated in CD34+ JAK2V617F Mutated Cells from Primary Myelofibrosis Patients

Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib

Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib

In vitro apoptotic response of freshly isolated chronic myeloid leukemia cells to all-trans retinoic acid and cytosine arabinoside

In vitro sensitivity of B-CLL cells to fludarabine and interferons

Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide

Infection control in patients with myelodysplastic syndromes who are candidates for active treatment: Expert panel consensus-based recommendations

Inhibition of TLR4 Signaling Affects Mitochondrial Fitness and Overcomes Bortezomib Resistance in Myeloma Plasma Cells

Intravenous injection of bortezomib, melphalan and dexamethasone in refractory and relapsed multiple myeloma

Iron toxicity - Its effect on the bone marrow

Is endoscopic ultrasound clinically useful for follow-up of gastric lymphoma?

Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine-Results from the Italian 'Back to Life' project

Luteinizing hormone-releasing hormone (LHRH) agonist restoration of age-associated decline of thymus weight, thymic LHRH receptors, and thymocyte proliferative capacity.

M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro.

Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of Ruxolitinib

Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients

Minimal Residual Disease Assessment Within the Bone Marrow of Multiple Myeloma: A Review of Caveats, Clinical Significance and Future Perspectives

Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells

Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic Syndromes

Monocytic Myeloid Derived Suppressor Cells in Hematological Malignancies ⬇️

Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib

Multicentric Castleman Disease and Concurrent Hematological Disorders: The Occurrence of Plasmacytoma and the Hypotheses Arising from Literature Review

Multidrug resistance mechanisms in chronic lymphocytic leukaemia

Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population.

Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients.

Nasal neutrophilia and eosinophilia induced by challenge with platelet activating factor

Neuroendocrine modulation of lymphocyte's activity during the physiological menstrual cycle

Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation.

PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy.

Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes

Peptidergic modulation of immune system development: Role of luteinizing hormone-releasing hormone

Peripheral blood stem cell contamination evaluated by a highly sensitive molecular method fails to predict outcome of autotransplanted multiple myeloma patients.

Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy Via STAT3

Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy.

Prognostic value of CD34+ peak in peripheral blood during mobilization in intermediate-risk AML patients treated in first CR by autologous or allogeneic transplantation

Proteomic Analysis Reveals Autophagy as Pro-Survival Pathway Elicited by Long-Term Exposure with 5-Azacitidine in High-Risk Myelodysplasia.

Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by Rituximab

Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis

Ruxolitinib in elderly patients with myelofibrosis: impact of age and genotype. A multicentre study on 291 elderly patients

SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation

Salvage therapy with pegylated liposomal doxorubicin, bortezomib, cyclophosphamide, and dexamethasone in relapsed/refractory myeloma patients.

Significant co-expression of WT1 and MDR1 genes in acute myeloid leukemia patients at diagnosis.

Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders.

TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma